IAP Position Paper on Burden of Mumps in India and Vaccination Strategies

Vipin M Vashishtha1, Sangeeta Yadav, Aashima Dabas

  • 1Indian Academy of Pediatrics, Advisory Committee on Vaccines and Immunization Practices (ACVIP); and Departments of Pediatrics, *Maulana Azad Medical College and #University College of Medical Sciences, New Delhi; India. Correspondence to: Dr Vipin M Vashishtha, Convener, IAP Advisory Committee on Vaccines and Immunization Practices, Mangla Hospital and Research Center, Shakti Chowk, Bijnor, Uttar Pradesh 246 701, India. vipinipsita@gmail.com.

Indian Pediatrics
|June 30, 2015
PubMed
Abstract

Insights

Mumps is a significant public health concern in India, with outbreaks reported nationwide and high susceptibility in children and adolescents. Including mumps vaccination in the National Immunization Program is crucial for disease control.

Area of Science:

  • Epidemiology
  • Immunization
  • Public Health

Background:

  • Mumps is prevalent in India but underestimated due to poor documentation and limited research.
  • The Indian government is considering the measles-rubella (MR) vaccine, potentially overlooking the mumps component.

Purpose of the Study:

  • To review the community burden of mumps in India.
  • To discuss vaccination strategies for policymakers to integrate mumps vaccine into the National Immunization Program.

Main Methods:

  • A comprehensive review of mumps burden and vaccination strategies in India was conducted.
  • Data from the Indian Academy of Pediatrics (IAP) Infectious Disease Surveillance (ID Surv) portal and the Government of India's Integrated Disease Surveillance Program (IDSP) were analyzed.
  • 14 studies and 2 media reports on mumps outbreaks were retrieved and analyzed.

Main Results:

  • Mumps outbreaks occurred across India, with mumps meningoencephalitis accounting for 2.3%–14.6% of encephalitis cases.
  • IDSP investigated 72 outbreaks involving 1564 cases in 14 states.
  • Genotypes G (G2) and C were the predominant circulating mumps virus strains.
  • Susceptibility rates in children and adolescents ranged from 32% to 80%.

Conclusions:

  • Mumps represents a substantial disease burden in India.
  • There is a clear need to include mumps vaccination in the National Immunization Program to mitigate its impact.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.1K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
51
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
121
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
58
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K